In Brazil, without considering the non-melanoma skin tumors, bladder cancer in men is the eighth most common, and the urothelial carcinoma
or transitional cell carcinoma is the most common among these. Cutaneous metastases from urothelial neoplasms appear as single or multiple
erythematous, infiltrated nodules or plaques, and like other cases of distant disease, it is indicative of poor prognosis. The invasive
urothelial carcinoma is recognized for its ability to present divergent differentiation and morphological variants. The sarcomatoid
urothelial carcinoma is a rare cancer that consists of two different components: one composed of epithelial tissue and the other with
sarcomatoid features of mesenchymal origin. The authors describe a case of cutaneous metastasis of sarcomatoid urothelial carcinoma in a
63-year-old male patient. Vesical neoplasms are important in view of the severity of symptoms involved, high recidivism rates and treatment
morbidity.1 Bladder tumor is the most common genitourinary tract cancer, the ninth most common cancer in the world, with over 330,000 new
cases/year, more than 30,000 deaths/year and a 3.8:1 rate between men and women.2,3 In Brazil, without taking into account non melanoma skin
cancer, bladder cancer is the eighth most frequent in male patients (6.89/100 thousand men); in women, it is the 15th most frequent
(2.15/100 thousand women).4 The smoking habit is the most important risk factor for this type of cancer, responsible for approximately
50-65% of new cases in men and 20-30% of cases in women.5 The second risk factor to be emphasized is occupational exposure (polycyclic
aromatic hydrocarbons, formaldehydes and solvents).6 Chronic aggression to vesical mucosa resulting from long periods of time wearing a
vesical catheter, untreated vesical lithiasis and cystitis caused by Schistosoma hematobium are also associated with the onset of squamous
cell carcinoma in the bladder.1 The most common bladder cancer is the urothelial cell carcinoma, also known as transitional cell carcinoma.
In approximately 30% of patients it is only diagnosed when there is invasion of the muscle layer.6 Histologically considered, the wall of
the urinary bladder is composed of three layers: one external tunica adventitia of connective tissue which, in some areas, is lined by a
serous peritoneal membrane, a non striated tunica muscularis (detrusor bladder muscle) and an internal mucosa membrane that lines the
interior of the bladder (tunica mucosae or urothelium).7 Normal urothelium is formed by three to seven cellular layers that are on top of
the corion, which contains the muscular layer of the mucosa.8 The deeper cells are called basal and the superficial ones have a wide and
flat umbrella shape. Among them there are one or more layers of intermediary cells.1,7,8 The transitional or urothelial cell carcinoma is
different from normal epithelium as it presents an increased number of cellular layers, with a papillary aspect and loss of cellular
architecture and polarity. They may present a papillary, nodular, sessile, infiltrative and mixed pattern. They may grow in depth, invading
the corion and the muscular layer characteristic of the bladder.1,9 The cutaneous metastasis of a visceral primary tumor is uncommon and its
incidence varies between 0.2% and 10.4%; the most common primary tumors that metastasize the skin depend on the gender of the affected
patient and include breast (69%), followed by colon (9%), lung (4%) and ovary (4%) in women and lung (24%), followed by colon (19%) and head
and neck tumors (12%) in men.10-12 As regards malignancy of the genitourinary tract, the incidence of skin involvement is between 1.1% and
2.5% of cases, corresponding to 3.4% of renal cell carcinomas and only 0.84% of urothelial carcinomas. The transitional cell carcinoma
usually metastasizes to lymph nodes, liver, lungs, bones and adrenal glands; cutaneous metastasis is considered rare.13,14 Visceral tumors
may metastasize to the skin through four mechanisms: (a) direct invasion from a neoplasm of underlying tissue (contiguity); (b) iatrogenic
implantation on the surgical wound; (c) lymphatic dissemination; (d) hematogenic dissemination.10,12,13 It should be noted that even
superficial urothelial carcinomas show some kind of dissemination in 20% of the cases; there may be cutaneous metastasization even in
absence of muscle-invasive disease.13,15 Clinically, cutaneous metastases of urothelial neoplasms appear as plaques or either single or
multiple nodules, erythematous, infiltrated, with an ulcerated or necrotic aspect. Diagnosis may become difficult as other primary
dermatoses, such as hemangiomas, keratoacanthomas, herpes zoster, erysipelas, boils or even dermatitis associated with chemotherapy are
mimetized. They tipically affect the dermis rather than the epidermis.13-15 Histologically, cutaneous metastases of a visceral carcinoma
demonstrate an uncontrolled infiltrative growth with atypical epithelial cells disposed as single cells, narrow cords and nests, moving
through collagen bundles in the dermis (Figure 1).16 Lymphatic vascular invasion may be present, which favors the metastatic origin of the
tumor. Cutaneous metastases may cytologically resemble the primary tumor. However, they may be little differentiated and require
immunohistochemical staining to determine their primary origin.13,16,17 Figure 1Primary neoplasm invading bladder mucosa and muscles;
uncontrolled infiltrative growth with atypical epithelial cells. 2. Dissected collagen bundles; 3. Angiogenesis induced by neoplasm; 4.
Undifferentiated atypical epithelioid cells forming cords and irregular aggregates, without a definite architectural pattern. Primary
neoplasm invading bladder mucosa and muscles; uncontrolled infiltrative growth with atypical epithelial cells. 2. Dissected collagen
bundles; 3. Angiogenesis induced by neoplasm; 4. Undifferentiated atypical epithelioid cells forming cords and irregular aggregates, without
a definite architectural pattern. Male patient, 63 years old, mentioned history of hematuria and intermitent abdominal pain for seven
months. He had undergone multiple treatments for urinary infection without resolution of clinical symptoms. A genitourinary tract ultrasound
scan revealed a nodular and hyperechogenic image, measuring 37 mm in its larger diameter, located in the left anterolateral wall of the
bladder. As there was suspicion of vesical tumor, he underwent transurethral bladder resection; complementary laparotomy and cystectomy were
required due to perforation of the organ. Histopathological examination of the lesion revealed high grade urothelial carcinoma (WHO/ISUP)
with invasion of the muscle layer and presence of embolus in lymph vessel. Pathological staging: pT2a, pNx, pMx. One month after surgery the
patient was hospitalized due to abdominal distension and pain. During the physical examination he was without fever, eupneic, pulse 88 bpm,
blood pressure 110 x 70 mmHg. At the dermatological examination were observed: an infraumbilical scar, an erythematous-purpuric plaque,
infiltrated, measuring about 10 x 5 cm at the hypogastrium, fistula with urine drainage at midline, infraumbilical region and two
erythematous-wine colored nodules at midline, suprapubic region (Figure 2). Figure 2Erythematous purpuric plaque, infiltrated, located in
the infraumbilical midline scar and two erythematous-wine colored nodules in the midline, suprapubic region; the black arrow marks the
biopsied nodule. Suprapubic cystostomy with urine leakage Erythematous purpuric plaque, infiltrated, located in the infraumbilical midline
scar and two erythematous-wine colored nodules in the midline, suprapubic region; the black arrow marks the biopsied nodule. Suprapubic
cystostomy with urine leakage Tomography of the abdomen and pelvis with intravenous contrast demonstrated free liquid; multiple peritoneal
nodules of irregular outline and heterogeneous enhancement, suggesting secondary implants; important thickening of right vesical wall
associated with densification of adjacent fat and mass of heterogeneous enhancement infiltrating the abdominal wall up to the epidermis in
the hypogastrium region and on the pathway of the surgical incision, where densification of subcutaneous fat planes and cutaneous nodules
can be observed (Figure 3). Figure 3Tomography of abdomen and pelvis: (a) Cut at bladder level, thickening of right vesical wall associated
with densification of adjacent fat and mass of heterogeneous enhancement infiltrating the abdominal wall up to the epidermis (white arrows).
Contrast excreted by the kidneys in the interior of the bladder (dotted arrow); (b) Cut below the pubic symphysis, showing extension of the
same mass through the subcutaneous tissue and the biopsied nodule (white arrow); (c) Cut at kidney level showing free liquid (*) and
peritoneal nodules, of irregular outline and heterogeneous enhancement, suggestive of secondary implants (white arrows). Tomography of
abdomen and pelvis: (a) Cut at bladder level, thickening of right vesical wall associated with densification of adjacent fat and mass of
heterogeneous enhancement infiltrating the abdominal wall up to the epidermis (white arrows). Contrast excreted by the kidneys in the
interior of the bladder (dotted arrow); (b) Cut below the pubic symphysis, showing extension of the same mass through the subcutaneous
tissue and the biopsied nodule (white arrow); (c) Cut at kidney level showing free liquid (*) and peritoneal nodules, of irregular outline
and heterogeneous enhancement, suggestive of secondary implants (white arrows). A biopsy of one of the nodules located in the midline scar
was made and the histopathological examination revealed a neoplasm composed mainly of atypical epithelioid and pleomorphic cells, disposed
in large compact aggregates, without any characteristic architecture. Presence of numerous mitoses and areas of necrosis. The neoplasm
occupied the entire dermis (Figure 4). A revision of the histopathology of the bladder lesion demonstrated a neoplasm predominantly composed
of atypical epithelioid and pleomorphic cells, disposed in large compact aggregates, without any characteristic architecture. Presence of
numerous mitoses and areas of necrosis. A neoplasm reached the muscular layer (Figure 5). Skin - Histopathologic findings: neoplasm composed
predominantly of atypical and pleomorphic epithelioid cells, disposed in large compact aggregates, without any characteristic architecture.
Presence of numerous mitoses and areas of necrosis. The neoplasm occupies all the dermis (hematoxilin and eosin staining; (A) 4x; (B) 10x;
(C) 40x) Bladder - Histopathologic findings: neoplasm composed predominantly of atypical and pleomorphic epithelioid cells, disposed in
large compact aggregates, without any characteristic architecture. Presence of numerous mitoses and areas of necrosis. The neoplasm reaches
the muscular wall [hematoxilin and eosin staining; (A) 4x; (B) 10x; (C) 40x)]. An immunohistochemical examination of the bladder lesion
demonstrated neoplastic cells with the following immunomarking profile: immunopositivity with the antivimentin (diffuse) and cytokeratin
antibodies AE1/AE3 (rare cells); immunonegativity with the anti CD34 antibody (Figure 6). Bladder - immunomarking profile: immunopositivity
with anti vimentin (diffuse) (A, 4x; B, 40x) and cytokeratin AE1/AE3 (rare cells) (C, 4x; D, 40x) antibodies Skin - immunomarking profile:
immunopositivity with anti vimentin (diffuse) (A, 4x; B, 40x) An immunohistochemical examination of the cutaneous nodule showed neoplastic
cells with the following immunomarking profile: immunopositivity with the antivimentin antibody (diffuse); imunonegativity with all other
tested antibodies: cytokeratin-cocktail, clone AE1/AE3, CK5, CK7, CK20, melan-A, Renal Cell Carcinoma Marker (RCC); CD34, CD45 (LCA),
protein p63, prostatic specific antigen (PSA), smooth muscle actin, protein S-100 and epithelial membrane antigen (EMA) (Figure 7). The
patient was referred to oncology for treatment, but passed away thirty days after the diagnosis of cutaneous invasion. It is undeniable that
cancer is a public health problem, whose prevention and early diagnosis should be prioritized. The diagnosis of a tumor in advanced stage
implies in systemic treatment, that is, use of chemotherapy, hormone therapy or target-therapies. In these cases, local treatments, such as
radiotherapy or surgery, will usually have no curative effect.1,4 The invasive urothelial carcinoma is recognized for its capacity of
divergent differentiation and presentation of morphological variants. WHO acknowledges as main variants of the urothelial carcinoma:
squamous, glandular differentiation, nests, microcystic, micropapilliferous, lymphoepithelioma-simile, lymphoma-simile and plasmocytoid,
sarcomatoid (with and without heterologous elements), trophoblastic differentiation, clear cells and lipidic cells.18,19 The recognition of
morphological variants is of great importance in the differential diagnosis with non neoplastic lesions and other malignant neoplasms,
including secondary vesical involvement by another carcinoma or sarcoma. The presence of a morphological variant is associated with a more
aggressive biological behavior of urothelial carcinomas and may even reflect in the option for therapeutic conducts different from the
customarily used in the conventional urothelial carcinoma.4,19,20 The sarcomatoid bladder carcinoma is a rare neoplasm composed of two
different components. One is formed by epithelial tissue with malignant characteristics (carcinoma) and another has sarcomatoid
characteristics, of mesenchymal origin. Some authors suggest the use of the term sarcomatoid carcinoma for cases without heterologous
mesenchymal elements in the composition of fusiform cells. Macroscopically, they present as exophytic polypoid masses, voluminous (5.7cm on
average) and with necrosis and ulceration areas.20 Histogenesis is controversial. Some authors suggest that these tumors develop as a result
of the ability of undifferentiated, totipotentiary neoplastic cells to be the origin of multiple pathways of terminal differentiation in
histologically recognized mesenchymal and epithelial elements. As basis for this theory stand out the existence of immunoreactivity for
epithelial markers (cytokeratin and epithelial membrane antigen - EMA) in mesenchymal areas, as well as the presence of ultrastructural
epithelial differentiation parameters (desmosomes and tonofilaments) in sarcomatoid elements. Other authors defend the theory that there is
a tumoral "collision", saying that there are two independent malignant tumors, mutually invasive. A third theory points to the possibility
of occurrence of metaplasia of malignant epithelial elements to sarcomatoid elements, based on the presence of staining for keratins
(AE1/AE3) both in the epithelial component and in the mesenchymal component.19,20 The most frequently found epithelial component is the high
grade transitional carcinoma (80%), followed by squamous cell carcinoma (32%), adenocarcinoma (26%) and small cell carcinoma (5%). In about
33% of cases, two or more epithelial components may coexist. As for the mesenchymal components, the most frequent is the osteosarcoma (37%),
followed by the condrosarcoma (20-47%), the rabdomyosarcoma (20%), the undifferentiated sarcoma of fusiform cells (l7%) and leiomyosarcoma
(7%).20 As the transitional cell carcinomas, the sarcomatoid bladder carcinomas may present with hematuria, dysuria and urinary infection.
The histological diagnosis is done based on the hematoxilin-eosin test and immunohistochemical study (cytokeratins in the epithelial
component and vimentin, desmin HHF-35, SMA or S100 in the mesenchymal component).2,3,20 The differential diagnosis should be done with
primary sarcomas, primary carcinomas with stromal metaplasia, carcinomas with pseudosarcomatous stroma, sarcomas associated with
pseudoepitheliomatous hyperplasia, teratomas and prostate carcinomas with extension to the bladder. As a consequence of the rarity of
bladder sarcomas in adults, the hypothesis of sarcomatoid carcinoma should be considered in the presence of a malignant tumor of fusiform
cells until there is immunohistochemical confirmation.19,20 The cutaneous dissemination of urothelial neoplasms, as in other cases of
disease in distant sites, is indicative of poor prognosis. It occurs mostly in late phases of the tumor and are the first sign of
dissemination only in punctual cases. Its identification may be made difficult due to its presentation identical to primary skin diseases,
but should be part of the differential diagnosis in oncologic patients. In this case, as a result of the extension of the tumor and presence
of metastatic nodules in the scar of the surgical wound, the propagation of the carcinoma will probably have a mixed mechanism: contiguity
and iatrogenic implantation in the surgical wound. The sarcomatoid bladder carcinomas, although rare and of difficult diagnosis, deserve
special attention in consequence of their aggressive behavior. Conflict of Interests: None. Financial Support: None. Study carried out at
the laboratory Fonte Medicina Diagn√≥stica - Niteroi (RJ), Brazil.
